HC Wainwright Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: HC Wainwright
Rating: 0
Author: MarketBeat

View the latest stock recommendations issued by analysts at HC Wainwright. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from HC Wainwright's equity research team. MarketBeat is not affiliated with or endorsed by HC Wainwright.

36 Analysts
Updated 9/2/2026

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 2,092 Last 12 Months
Buy Ratings: 1,926 Last 12 Months
Sell Ratings: 11 Last 12 Months
Companies Covered: 648 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
ALMS Alumis	$10.49 +10.8%	9/2/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$25.00 ➝ $15.00	Neutral ➝ Buy	View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 9/2/2026
ALNY Alnylam Pharmaceuticals	$266.21 +8.2%	9/2/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$455.00	Buy	View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 9/2/2026
BBIO BridgeBio Pharma	$76.24 -0.4%	9/2/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$120.00	Buy	View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 9/2/2026
CLMT Calumet	$52.95 +2.8%	9/2/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$60.00 ➝ $75.00	Buy	View details for HC Wainwright rating of Calumet (NASDAQ:CLMT) on 9/2/2026
NUCL Eagle Nuclear Energy	$6.88 +3.4%	9/2/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$11.50	Buy	View details for HC Wainwright rating of Eagle Nuclear Energy (NASDAQ:NUCL) on 9/2/2026
TLX Telix Pharmaceuticals	$11.41 +5.2%	9/2/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	View details for HC Wainwright rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/2/2026
UPB Upstream Bio	$6.50 -0.8%	9/2/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$36.00	Buy	View details for HC Wainwright rating of Upstream Bio (NASDAQ:UPB) on 9/2/2026
BLSM BlossomHill Therapeutics	$19.32 +1.7%	9/1/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$35.00	Buy	View details for HC Wainwright rating of BlossomHill Therapeutics (NASDAQ:BLSM) on 9/1/2026
UUUU Energy Fuels	$14.19 -0.2%	9/1/2026	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$29.00 ➝ $29.25	Buy	View details for HC Wainwright rating of Energy Fuels (NYSEAMERICAN:UUUU) on 9/1/2026
ARWR Arrowhead Pharmaceuticals	$83.23 +0.6%	9/1/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$120.00	Buy	View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 9/1/2026
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
BLSM BlossomHill Therapeutics	$19.32 +1.7%	9/1/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$35.00	Buy	View details for HC Wainwright rating of BlossomHill Therapeutics (NASDAQ:BLSM) on 9/1/2026
CABA Cabaletta Bio	$3.52 +6.6%	9/1/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$16.00	Buy	View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 9/1/2026
KYNB Kyntra Bio	$8.47 +6.5%	9/1/2026	Matthew Keller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$43.00	Buy	View details for HC Wainwright rating of Kyntra Bio (NASDAQ:KYNB) on 9/1/2026
NKLR Terra Innovatum Global S.R.L.	$5.11 +1.6%	9/1/2026	Sameer Joshi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	View details for HC Wainwright rating of Terra Innovatum Global S.R.L. (NASDAQ:NKLR) on 9/1/2026
TGTX TG Therapeutics	$55.83 -0.5%	9/1/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$78.00	Buy	View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 9/1/2026
PTGX Protagonist Therapeutics	$146.59 +0.1%	8/31/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$167.00 ➝ $170.00	Buy	View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 8/31/2026
CRSP CRISPR Therapeutics	$56.38 -0.8%	8/31/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/31/2026
AXSM Axsome Therapeutics	$206.99 +2.1%	8/31/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$290.00	Buy	View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 8/31/2026
BMRN BioMarin Pharmaceutical	$66.33 +2.3%	8/31/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$59.00 ➝ $60.00	Neutral	View details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 8/31/2026
BWAY Brainsway	$14.27	8/31/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$17.00 ➝ $19.00	Buy	View details for HC Wainwright rating of Brainsway (NASDAQ:BWAY) on 8/31/2026
CYTK Cytokinetics	$70.87 -0.7%	8/31/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$140.00	Buy	View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 8/31/2026
GANX Gain Therapeutics	$1.78 +0.3%	8/31/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$8.00	Buy	View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 8/31/2026
IONS Ionis Pharmaceuticals	$60.95 +1.8%	8/31/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$115.00	Buy	View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 8/31/2026
SCTX Scribe Therapeutics	$30.95 +6.7%	8/31/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$60.00	Buy	View details for HC Wainwright rating of Scribe Therapeutics (NASDAQ:SCTX) on 8/31/2026
GENB Generate Biomedicines	$15.93 +0.9%	8/28/2026	Mitchell Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$25.00 ➝ $30.00	Buy	View details for HC Wainwright rating of Generate Biomedicines (NASDAQ:GENB) on 8/28/2026
IREN IREN	$37.79 +2.6%	8/28/2026	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$90.00	Buy	View details for HC Wainwright rating of IREN (NASDAQ:IREN) on 8/28/2026
BLCO Bausch + Lomb	$18.39 +2.8%	8/28/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$21.00	Buy	View details for HC Wainwright rating of Bausch + Lomb (NYSE:BLCO) on 8/28/2026
MBRX Moleculin Biotech	$0.69 +6.2%	8/28/2026	Sara Nik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$3.00	Buy	View details for HC Wainwright rating of Moleculin Biotech (NASDAQ:MBRX) on 8/28/2026
ROIV Roivant Sciences	$33.64 -2.6%	8/28/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$41.00	Buy	View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 8/28/2026
FSLR First Solar	$199.03 -0.3%	8/27/2026		Initiated Coverage		Buy	View details for HC Wainwright rating of First Solar (NASDAQ:FSLR) on 8/27/2026
GOSS Gossamer Bio	$0.17 +0.4%	8/27/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 8/27/2026
IMRX Immuneering	$4.87 +0.3%	8/27/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Immuneering (NASDAQ:IMRX) on 8/27/2026
VYGR Voyager Therapeutics	$3.50 +1.9%	8/27/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 8/27/2026
BHVN Biohaven	$15.79 +0.3%	8/27/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 8/27/2026
ODTX Odyssey Therapeutics	$25.91 +5.8%	8/27/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$44.00	Buy	View details for HC Wainwright rating of Odyssey Therapeutics (NASDAQ:ODTX) on 8/27/2026
ASND Ascendis Pharma A/S	$265.81 +2.1%	8/27/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$345.00	Buy	View details for HC Wainwright rating of Ascendis Pharma A/S (NASDAQ:ASND) on 8/27/2026
RVMD Revolution Medicines	$208.00 -0.9%	8/27/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$195.00 ➝ $280.00	Buy	View details for HC Wainwright rating of Revolution Medicines (NASDAQ:RVMD) on 8/27/2026
ASND Ascendis Pharma A/S	$265.81 +2.1%	8/27/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$345.00	Buy	View details for HC Wainwright rating of Ascendis Pharma A/S (NASDAQ:ASND) on 8/27/2026
ODTX Odyssey Therapeutics	$25.91 +5.8%	8/27/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$44.00	Buy	View details for HC Wainwright rating of Odyssey Therapeutics (NASDAQ:ODTX) on 8/27/2026
UEC Uranium Energy	$11.51 -0.7%	8/26/2026	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 8/26/2026
Why Boston Ships In Natural Gas It Already Has at Home (Ad) A tanker called the Iberica Knutsen once sailed 2,272 miles from Trinidad and Tobago to deliver liquefied natural gas to Boston. The odd part: the Marcellus Shale, one of the largest natural gas reserves in the world, sits just a few hundred miles away. Porter Stansberry spent years digging into why this happens and what it means for the American energy system. Uncover the full story behind Boston's costly LNG imports
SPRB Spruce Biosciences	$57.83 +4.0%	8/26/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Spruce Biosciences (NASDAQ:SPRB) on 8/26/2026
CRBP Corbus Pharmaceuticals	$11.30 +0.1%	8/26/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$35.00	Buy	View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 8/26/2026
GRO Brazil Potash	$2.52 -3.8%	8/26/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$4.75	Buy	View details for HC Wainwright rating of Brazil Potash (NYSEAMERICAN:GRO) on 8/26/2026
PDSB PDS Biotechnology	$0.21 +3.9%	8/26/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 8/26/2026
PHIO Phio Pharmaceuticals	$1.15 +4.1%	8/26/2026	Matthew Keller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Phio Pharmaceuticals (NASDAQ:PHIO) on 8/26/2026
SMMT Summit Therapeutics	$14.18 +0.1%	8/26/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 8/26/2026
ZYME Zymeworks	$30.62 +3.2%	8/26/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$51.00 ➝ $55.00	Buy	View details for HC Wainwright rating of Zymeworks (NASDAQ:ZYME) on 8/26/2026
MRVL Marvell Technology	$205.82 -2.2%	8/25/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Marvell Technology (NASDAQ:MRVL) on 8/25/2026
OCS Oculis	$12.01 -1.4%	8/25/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 8/25/2026
BEAM Beam Therapeutics	$28.50 -1.8%	8/25/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$80.00	Buy	View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 8/25/2026
EOLS Evolus	$9.01 -0.8%	8/25/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$13.00	Buy	View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 8/25/2026
FOCL FocalTherics	$4.27 -0.9%	8/25/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00	Buy	View details for HC Wainwright rating of FocalTherics (NASDAQ:FOCL) on 8/25/2026
NRXP NRx Pharmaceuticals	$3.43 -0.4%	8/25/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 8/25/2026
RGNX REGENXBIO	$9.38 +0.6%	8/25/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$23.00 ➝ $21.00	Buy	View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 8/25/2026
SGMT Sagimet Biosciences	$10.68 +1.7%	8/25/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$29.00	Buy	View details for HC Wainwright rating of Sagimet Biosciences (NASDAQ:SGMT) on 8/25/2026
BMEA Biomea Fusion	$1.87 +3.6%	8/24/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 8/24/2026
ACIU AC Immune	$2.77 +3.2%	8/24/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 8/24/2026
COYA Coya Therapeutics	$4.40 -2.5%	8/24/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Coya Therapeutics (NASDAQ:COYA) on 8/24/2026
FLYX flyExclusive	$1.19 -0.4%	8/24/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of flyExclusive (NYSE:FLYX) on 8/24/2026
AXSM Axsome Therapeutics	$206.99 +2.1%	8/24/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 8/24/2026
CLYM Climb Bio	$15.10 +1.9%	8/24/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$20.00 ➝ $24.00	Buy	View details for HC Wainwright rating of Climb Bio (NASDAQ:CLYM) on 8/24/2026
ANAB AnaptysBio	$55.17 -0.2%	8/24/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$95.00	Buy	View details for HC Wainwright rating of AnaptysBio (NASDAQ:ANAB) on 8/24/2026
AQST Aquestive Therapeutics	$5.34 +1.8%	8/24/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00	Buy	View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 8/24/2026
BCDA BioCardia	$1.12 +1.4%	8/24/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of BioCardia (NASDAQ:BCDA) on 8/24/2026
FURY Fury Gold Mines	$0.59 -0.2%	8/24/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$2.00 ➝ $1.90	Buy	View details for HC Wainwright rating of Fury Gold Mines (NYSEAMERICAN:FURY) on 8/24/2026
INBX Inhibrx Biosciences	$124.52 -0.1%	8/24/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$245.00	Buy	View details for HC Wainwright rating of Inhibrx Biosciences (NASDAQ:INBX) on 8/24/2026
LBRX LB Pharmaceuticals	$49.28 +4.6%	8/24/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$45.00 ➝ $60.00	Buy	View details for HC Wainwright rating of LB Pharmaceuticals (NASDAQ:LBRX) on 8/24/2026
NMG Nouveau Monde Graphite	$1.42 +0.4%	8/24/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$4.50	Buy	View details for HC Wainwright rating of Nouveau Monde Graphite (NYSE:NMG) on 8/24/2026
WULF TeraWulf	$14.57 -0.6%	8/21/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of TeraWulf (NASDAQ:WULF) on 8/21/2026
LFWD Lifeward	$7.31 +1.5%	8/21/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00	Buy	View details for HC Wainwright rating of Lifeward (NASDAQ:LFWD) on 8/21/2026
MRKR Marker Therapeutics	$1.27 -2.7%	8/21/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Marker Therapeutics (NASDAQ:MRKR) on 8/21/2026
LYTS LSI Industries	$19.95 +1.7%	8/21/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of LSI Industries (NASDAQ:LYTS) on 8/21/2026
IMA ImageneBio	$5.02 -0.1%	8/21/2026	Arthur He Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$28.00	Buy	View details for HC Wainwright rating of ImageneBio (NASDAQ:IMA) on 8/21/2026
ELBM Electra Battery Materials	$0.57 -3.0%	8/21/2026	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$2.10 ➝ $2.00	Buy	View details for HC Wainwright rating of Electra Battery Materials (NASDAQ:ELBM) on 8/21/2026
COCH Envoy Medical	$0.71 +1.2%	8/21/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$2.50 ➝ $2.00	Buy	View details for HC Wainwright rating of Envoy Medical (NASDAQ:COCH) on 8/21/2026
IMA ImageneBio	$5.02 -0.1%	8/21/2026	Arthur He Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$28.00	Buy	View details for HC Wainwright rating of ImageneBio (NASDAQ:IMA) on 8/21/2026
RANI Rani Therapeutics	$0.84 -2.4%	8/21/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Rani Therapeutics (NASDAQ:RANI) on 8/21/2026
DRD DRDGOLD	$28.40 +2.5%	8/20/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$33.00 ➝ $35.00	Buy	View details for HC Wainwright rating of DRDGOLD (NYSE:DRD) on 8/20/2026
INCY Incyte	$127.00 +1.6%	8/20/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$150.00	Buy	View details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 8/20/2026
KRRO Korro Bio	$12.05 -1.6%	8/20/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$15.00	Buy	View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 8/20/2026
NBP I-Mab	$1.77 +2.0%	8/20/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$9.00	Buy	View details for HC Wainwright rating of I-Mab (NASDAQ:NBP) on 8/20/2026
RLAY Relay Therapeutics	$18.45 -0.2%	8/20/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$28.00 ➝ $29.00	Buy	View details for HC Wainwright rating of Relay Therapeutics (NASDAQ:RLAY) on 8/20/2026
SPTX Seaport Therapeutics	$24.78 +5.0%	8/20/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$50.00	Buy	View details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 8/20/2026
ZVRA Zevra Therapeutics	$12.19 +1.0%	8/20/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$26.00	Buy	View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 8/20/2026
MBOT Microbot Medical	$1.48 +0.3%	8/19/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 8/19/2026
ASTI Ascent Solar Technologies	$2.85 +1.4%	8/19/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Ascent Solar Technologies (NASDAQ:ASTI) on 8/19/2026
CTXR Citius Pharmaceuticals	$0.58 +2.3%	8/19/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 8/19/2026
SJM J. M. Smucker	$132.40 +0.7%	8/19/2026		Set Price Target	$123.00		View details for HC Wainwright rating of J. M. Smucker (NYSE:SJM) on 8/19/2026
DRUG Bright Minds Biosciences	$72.19 +1.9%	8/19/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$145.00	Buy	View details for HC Wainwright rating of Bright Minds Biosciences (NASDAQ:DRUG) on 8/19/2026
ONCY Oncolytics Biotech	$0.90 +7.0%	8/19/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$5.00	Buy	View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 8/19/2026
Bezos… DOOMED (Ad) A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25. Watch James Altucher's free video breakdown before the September 25 deadline.
USAS Americas Gold and Silver	$5.38 +6.4%	8/19/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$9.75 ➝ $9.25	Buy	View details for HC Wainwright rating of Americas Gold and Silver (NYSEAMERICAN:USAS) on 8/19/2026
JSPR Jasper Therapeutics	$0.71 +1.8%	8/18/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Jasper Therapeutics (NASDAQ:JSPR) on 8/18/2026
PPSI Pioneer Power Solutions	$2.88 +0.7%	8/18/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Pioneer Power Solutions (NASDAQ:PPSI) on 8/18/2026
IVVD Invivyd	$0.79 -10.8%	8/18/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 8/18/2026
ACTU Actuate Therapeutics	$1.36 -11.7%	8/18/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Actuate Therapeutics (NASDAQ:ACTU) on 8/18/2026
AMLX Amylyx Pharmaceuticals	$34.57 +2.3%	8/18/2026	Andrew S. Fein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$34.00 ➝ $55.00	Buy	View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 8/18/2026
ARGX argenex	$1,045.31 +1.6%	8/18/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$940.00 ➝ $1,202.00	Buy	View details for HC Wainwright rating of argenex (NASDAQ:ARGX) on 8/18/2026
ASMB Assembly Biosciences	$36.18 +2.8%	8/18/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$50.00	Buy	View details for HC Wainwright rating of Assembly Biosciences (NASDAQ:ASMB) on 8/18/2026
BMRN BioMarin Pharmaceutical	$66.33 +2.3%	8/18/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$60.00 ➝ $59.00	Neutral	View details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 8/18/2026
ELTX Elicio Therapeutics	$2.52 -1.8%	8/18/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Elicio Therapeutics (NASDAQ:ELTX) on 8/18/2026

MarketBeat Community Rating for HC Wainwright

MarketBeat's community ratings are surveys of what our community members think about HC Wainwright and other research firms in the last 90 days. Vote "Outperform" if you believe HC Wainwright's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe HC Wainwright's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES: 0 Believe will outperform the market
UNDERPERFORM VOTES: 0 Believe will underperform the market

Analysts at HC Wainwright

HC Wainwright's equity research team has issued ratings on 645 companies across 11 sectors over the past 12 months, covered by 36 analysts. The HC Wainwright analysts below are listed by number of ratings issued in the last year.

HC Wainwright Stock Coverage by Sector

HC Wainwright concentrates its research most heavily in Healthcare (73.1%), Technology (8.5%) and Materials (6.2%). The chart below shows how HC Wainwright's 648 rated companies are distributed across all 11 sectors it covers.

Healthcare
474 companies
73.1%
Technology
55 companies
8.5%
Materials
40 companies
6.2%
Industrials
35 companies
5.4%
Finance
15 companies
2.3%
Energy
12 companies
1.9%
Consumer Staples
5 companies
0.8%
Consumer Discretionary
3 companies
0.5%
Utilities
3 companies
0.5%
Communication Services
2 companies
0.3%
Real Estate
1 company
0.2%

Best & Worst Calls

Best Call
000000.0%
NASDAQ:NVAX
Initiated Coverage • Jan 22, 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
0000.0%
NASDAQ:EFTR
Reiterated Rating • Nov 14, 2023
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

HC Wainwright - Frequently Asked Questions

HC Wainwright's analysts currently have buy-equivalent ratings on 610 companies. Recent upgrades to buy include Alumis and Prime Medicine.

HC Wainwright's highest-rated analysts by MarketBeat's accuracy score include Raghuram Selvaraju, Andrew Fein and Mitchell Kapoor. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 36 analysts at HC Wainwright.

HC Wainwright has the deepest coverage in Healthcare (73.1% of rated companies), Technology (8.5% of rated companies), Materials (6.2% of rated companies), Industrials (5.4% of rated companies) and Finance (2.3% of rated companies).

HC Wainwright issued 2,092 ratings over the last 12 months across 648 companies â€” an average of roughly 174 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current HC Wainwright analyst actions.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?